Compare $ABVC vs $MCRB | Chartloom

Compare

$ABVC vs $MCRB

ABVC Biopharma Inc · Seres Therapeutics Inc

ABVC

ABVC Biopharma Inc

MCRB

Seres Therapeutics Inc

Compare $ABVC vs $MCRB

Comparing ABVC Biopharma Inc and Seres Therapeutics Inc

ABVCABVC Biopharma Inc

MCRBSeres Therapeutics Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

MCRB

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

MCRB

Seres Therapeutics Inc

Market Cap

ABVC$26M

MCRB$26M

Enterprise Value

ABVC$27M

MCRB$11M

Price

ABVC$1.00

MCRB$2.71

P/E Ratio

ABVCN/A

MCRBN/A

P/S Ratio

ABVC39.44x

MCRB13.93x

EV/Sales

ABVC40.47x

MCRB5.65x

EV/EBITDA

ABVC0.00x

MCRB0.00x

P/B Ratio

ABVC3.06x

MCRB0.85x

P/FCF Ratio

ABVCN/A

MCRBN/A

EV/FCF

ABVC-9.95x

MCRB-0.21x

PEG Ratio

ABVCN/A

MCRBN/A

Forward P/E (NTM)

ABVCN/A

MCRBN/A

Forward P/S (NTM)

ABVCN/A

MCRBN/A

Revenue (TTM)

ABVC$0

MCRB$2M

Revenue Growth (YoY)

ABVC-100.0%

MCRBN/A

Forward Rev Growth

ABVC0.0%

MCRB-98.0%

Gross Margin (TTM)

ABVC0.3%

MCRB0.0%

Operating Margin (TTM)

ABVC0.0%

MCRB0.0%

EBITDA Margin (TTM)

ABVC0.0%

MCRB-3971.2%

Net Margin (TTM)

ABVC0.0%

MCRB-1192.9%

FCF Margin (TTM)

ABVCN/A

MCRB-2724.1%

Net Income (TTM)

ABVC$-8M

MCRB$-22M

FCF (TTM)

ABVC$-3M

MCRB$-51M

EPS (TTM)

ABVC-$0.30

MCRB-$2.30

ROE (TTM)

ABVC-7147.0%

MCRB-6032.0%

ROA (TTM)

ABVC-3883.0%

MCRB-1794.0%

ROIC (TTM)

ABVC-6509.0%

MCRB-6032.0%

Cash

ABVC$32K

MCRB$16M

Debt

ABVC$859K

MCRB$0

Net Cash/Debt

ABVC$-827K

MCRB$16M

Current Ratio (TTM)

ABVC0.07x

MCRB2.11x

Quick Ratio (TTM)

ABVC0.05x

MCRB2.04x

Debt/Equity (TTM)

ABVC0.08x

MCRB0.00x

Debt/Assets (TTM)

ABVC0.0%

MCRB0.0%

Interest Coverage (TTM)

ABVCN/A

MCRBN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

MCRB0.00x

Beta

ABVC0.50

MCRB0.49

52W Performance

ABVC-69.1%

MCRB-86.2%

YTD Performance

ABVC-54.3%

MCRB-82.1%

% from 52W High

ABVC-70.0%

MCRB-91.0%

% from 52W Low

ABVC40.8%

MCRB12.0%

Asset Turnover (TTM)

ABVC0.06x

MCRB0.02x

FCF Yield (TTM)

ABVC-10.4%

MCRB-195.5%

Earnings Yield (TTM)

ABVC-30.4%

MCRB-85.6%

Dividend Yield (TTM)

ABVCN/A

MCRBN/A

Rule of 40

ABVC-100.0

MCRB-2,724.1

EV/GP/RG

ABVCN/A

MCRBN/A

Ticker research

View ABVC research View MCRB research

Metric	ABVC ABVC Biopharma Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$26M	$26M
Enterprise Value	$27M	$11M
Price	$1.00	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	13.93x
EV/Sales	40.47x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3971.2%
Net Margin (TTM)	0.0%	-1192.9%
FCF Margin (TTM)	N/A	-2724.1%
Net Income (TTM)	$-8M	$-22M
FCF (TTM)	$-3M	$-51M
EPS (TTM)	-$0.30	-$2.30
ROE (TTM)	-7147.0%	-6032.0%
ROA (TTM)	-3883.0%	-1794.0%
ROIC (TTM)	-6509.0%	-6032.0%
Financial Health
Cash	$32K	$16M
Debt	$859K	$0
Net Cash/Debt	$-827K	$16M
Current Ratio (TTM)	0.07x	2.11x
Quick Ratio (TTM)	0.05x	2.04x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.49
52W Performance	-69.1%	-86.2%
YTD Performance	-54.3%	-82.1%
% from 52W High	-70.0%	-91.0%
% from 52W Low	40.8%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-10.4%	-195.5%
Earnings Yield (TTM)	-30.4%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View MCRB research

Valuation

P/S Ratio

MCRB

13.93x

ABVC

39.44x

EV/FCF

ABVC

-9.95x

MCRB

-0.21x

Growth & revenue

Revenue Growth TTM

ABVC

-100.0%

Forward Revenue Growth

ABVC

0.0%

MCRB

-98.0%

Profitability & performance

Gross Margin

ABVC

0.3%

MCRB

0.0%

ROE

MCRB

-6032.0%

ABVC

-7147.0%

FCF Yield %

ABVC

-10.4%

MCRB

-195.5%

52-Week Performance

ABVC

-69.1%

MCRB

-86.2%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

MCRB

Seres Therapeutics Inc

Market Cap

ABVC$26M

MCRB$26M

Enterprise Value

ABVC$27M

MCRB$11M

Price

ABVC$1.00

MCRB$2.71

P/E Ratio

ABVCN/A

MCRBN/A

P/S Ratio

ABVC39.44x

MCRB13.93x

EV/Sales

ABVC40.47x

MCRB5.65x

EV/EBITDA

ABVC0.00x

MCRB0.00x

P/B Ratio

ABVC3.06x

MCRB0.85x

P/FCF Ratio

ABVCN/A

MCRBN/A

EV/FCF

ABVC-9.95x

MCRB-0.21x

PEG Ratio

ABVCN/A

MCRBN/A

Forward P/E (NTM)

ABVCN/A

MCRBN/A

Forward P/S (NTM)

ABVCN/A

MCRBN/A

Revenue (TTM)

ABVC$0

MCRB$2M

Revenue Growth (YoY)

ABVC-100.0%

MCRBN/A

Forward Rev Growth

ABVC0.0%

MCRB-98.0%

Gross Margin (TTM)

ABVC0.3%

MCRB0.0%

Operating Margin (TTM)

ABVC0.0%

MCRB0.0%

EBITDA Margin (TTM)

ABVC0.0%

MCRB-3971.2%

Net Margin (TTM)

ABVC0.0%

MCRB-1192.9%

FCF Margin (TTM)

ABVCN/A

MCRB-2724.1%

Net Income (TTM)

ABVC$-8M

MCRB$-22M

FCF (TTM)

ABVC$-3M

MCRB$-51M

EPS (TTM)

ABVC-$0.30

MCRB-$2.30

ROE (TTM)

ABVC-7147.0%

MCRB-6032.0%

ROA (TTM)

ABVC-3883.0%

MCRB-1794.0%

ROIC (TTM)

ABVC-6509.0%

MCRB-6032.0%

Cash

ABVC$32K

MCRB$16M

Debt

ABVC$859K

MCRB$0

Net Cash/Debt

ABVC$-827K

MCRB$16M

Current Ratio (TTM)

ABVC0.07x

MCRB2.11x

Quick Ratio (TTM)

ABVC0.05x

MCRB2.04x

Debt/Equity (TTM)

ABVC0.08x

MCRB0.00x

Debt/Assets (TTM)

ABVC0.0%

MCRB0.0%

Interest Coverage (TTM)

ABVCN/A

MCRBN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

MCRB0.00x

Beta

ABVC0.50

MCRB0.49

52W Performance

ABVC-69.1%

MCRB-86.2%

YTD Performance

ABVC-54.3%

MCRB-82.1%

% from 52W High

ABVC-70.0%

MCRB-91.0%

% from 52W Low

ABVC40.8%

MCRB12.0%

Asset Turnover (TTM)

ABVC0.06x

MCRB0.02x

FCF Yield (TTM)

ABVC-10.4%

MCRB-195.5%

Earnings Yield (TTM)

ABVC-30.4%

MCRB-85.6%

Dividend Yield (TTM)

ABVCN/A

MCRBN/A

Rule of 40

ABVC-100.0

MCRB-2,724.1

EV/GP/RG

ABVCN/A

MCRBN/A

Ticker research

View ABVC research View MCRB research

Metric	ABVC ABVC Biopharma Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$26M	$26M
Enterprise Value	$27M	$11M
Price	$1.00	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	13.93x
EV/Sales	40.47x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3971.2%
Net Margin (TTM)	0.0%	-1192.9%
FCF Margin (TTM)	N/A	-2724.1%
Net Income (TTM)	$-8M	$-22M
FCF (TTM)	$-3M	$-51M
EPS (TTM)	-$0.30	-$2.30
ROE (TTM)	-7147.0%	-6032.0%
ROA (TTM)	-3883.0%	-1794.0%
ROIC (TTM)	-6509.0%	-6032.0%
Financial Health
Cash	$32K	$16M
Debt	$859K	$0
Net Cash/Debt	$-827K	$16M
Current Ratio (TTM)	0.07x	2.11x
Quick Ratio (TTM)	0.05x	2.04x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.49
52W Performance	-69.1%	-86.2%
YTD Performance	-54.3%	-82.1%
% from 52W High	-70.0%	-91.0%
% from 52W Low	40.8%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-10.4%	-195.5%
Earnings Yield (TTM)	-30.4%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View MCRB research